Michael Berendt

Michael Berendt

Chairman at
Anchor Therapeutics, Inc.
77 year
Health Technology
Finance
Consumer Services

Profile

Michael J.
Berendt
is currently the Executive Chairman at Anchor Therapeutics, Inc. He previously served as the President & Chief Executive Officer at Aegera Therapeutics, Inc. and as the Group Director-Drug Discovery at Pfizer Inc. He has also served as an Independent Director at Waters Corp.
and as a Director at Onyx Pharmaceuticals, Inc. and Myriad Genetics, Inc. Additionally, he was the Managing Director at AEA Investors LP and RCT BioVentures.
He served as the Director, Chief Executive & Scientific Officer at Telesta Therapeutics, Inc. and as a Director at Northstar Neuroscience, Inc., Catalyst Bioscience, Inc., Trillium Therapeutics, Inc., Alethia Biotherapeutics, Inc., Research Corporation Technologies, Inc., Neomed Institute, and ProMetic Plasma Resources, Inc. He holds a doctorate degree from Drexel University, a graduate degree from Miami University, and an undergraduate degree from Ohio Dominican University.

Michael Berendt active positions

CompaniesPositionStart
Chairman -

Former positions of Michael Berendt

CompaniesPositionEnd
WATERS CORPORATION Director/Board Member 05/10/2021
TELESTA THERAPEUTICS INC Chief Executive Officer 01/11/2016
Director/Board Member 06/06/2014
Chief Executive Officer 01/07/2011
Corporate Officer/Principal 01/12/2005
See the detail of Michael Berendt's experience

Training of Michael Berendt

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

80

1st degree connections

20

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies20

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Consumer Services

Consumer Services

Consumer Services

Health Technology

Commercial Services

Health Technology

Finance

Health Technology

Health Services

  1. Stock Market
  2. Insiders
  3. Michael Berendt
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!